首页> 外国专利> HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME FOR DETERMINING THE ETIOLOGY OF PERI-ORBITAL PUFFINESS

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME FOR DETERMINING THE ETIOLOGY OF PERI-ORBITAL PUFFINESS

机译:透明质酸酶组合物和使用该组合物的方法,用于确定Peri-orbital Puffiness的病因

摘要

The present disclosure provides methods for determining an etiology of upper and/or lower eyelid puffiness by examining a subject with squinted eyes; and determining if upper and/or lower eyelid puffiness does not improve, improves, partially improves, or worsens, wherein the etiology of the upper and/or lower eyelid puffiness is diagnosed to be anterior to the orbicularis oculi muscle if the puffiness does not improve, wherein the etiology of the upper and/or lower eyelid puffiness is determined to be posterior to the orbicularis oculi muscle if the puffiness improves, wherein the etiology of the upper and/or lower eyelid puffiness is determined to be anterior and posterior to the orbicularis oculi muscle if the puffiness partially improves, or wherein the puffiness is determined to be secondary to hypertrophy of the orbicularis muscle or if the puffiness worsens.
机译:本公开提供了通过检查具有斜视眼的受试者来确定上/或下眼睑肿瘤的病因的方法;并确定上/ /或下眼睑肿瘤是否没有改善,改善,部分地改善或恶化,其中如果浮肿没有改善,则诊断出上/或下眼睑浮肿的病因,诊断为腹膜肌肉肌肉末端,其中如果浮肿改善,确定上眼睑和/或下眼睑肿瘤的病因被确定为后肌肌肌,其中,上/ /或下眼睑浮肿的病因被确定为腹部和后腹板oculi肌肉如果浮肿部分改善,或者其中浮肿被确定为次要的腹部肌肉的肥大,或者如果浮肿恶化。

著录项

  • 公开/公告号US2021236049A1

    专利类型

  • 公开/公告日2021-08-05

    原文格式PDF

  • 申请/专利权人 STANDARD OF CARE CORPORATION;

    申请/专利号US202016840255

  • 发明设计人 ILIANA E. SWEIS;BRYAN C. CRESSEY;

    申请日2020-04-03

  • 分类号A61B5;A61K38/47;

  • 国家 US

  • 入库时间 2022-08-24 20:21:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号